CIK 0001253689 · Non-accelerated filer<br>Smaller reporting company
CRESCENT BIOPHARMA, INC.
Sign in to watch- Ticker
- CBIO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Cayman Islands
- Entity type
- operating
- Phone
- 617-430-5595
- Business address
- 300 FIFTH AVENUE, WALTHAM, MA, 02451
- Former names
- GLYCOMIMETICS INC
- 8-K Event Delisting notice
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 8-K Event Executive or director change · Shareholder vote results
- 424B5 Offering Prospectus
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- EFFECT Other Notice of Effectiveness
- CORRESP Other Correspondence Between Filers and SEC Staff
- DEF 14A Proxy Proxy Statement
- 4 Open-market sale SVP of Research, CSO sold 3,227 shares at $1.09 ($3,517)
- 4 Open-market sale SVP, Chief Business Officer sold 2,339 shares at $1.09 ($2,550)
- 4 Open-market sale SVP Finance, CFO sold 2,917 shares at $1.09 ($3,180)
- UPLOAD Other SEC-generated Letter
- S-3 Offering Registration Statement
Page 15 of 34 · 678 filings